Pneumococcal vaccination in developing countries
暂无分享,去创建一个
T. Cherian | S. Madhi | K. O'Brien | C. Whitney | R. Adegbola | J. Scott | B. Greenwood | F. Cutts | D. Goldblatt | R. Dagan | M. Santosham | O. Levine | K. Klugman | K. Mulholland | S. Sow | S. Saha | S. Black | H. Nohynek | M. Knoll | A. Grange | Tom Hennessy | J. Scott | Keith P. Klugman | Thomas W. Hennessy | Felicity T. Cutts
[1] S. Madhi,et al. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] S. Obaro,et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial , 2005, The Lancet.
[3] K. Maitland,et al. Bacteremia among children admitted to a rural hospital in Kenya. , 2005, The New England journal of medicine.
[4] M. Levine,et al. Invasive Pneumococcal Infections Among Hospitalized Children in Bamako, Mali , 2004, The Pediatric infectious disease journal.
[5] S. Madhi,et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. , 2003, The New England journal of medicine.
[6] A. Schuchat,et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The New England journal of medicine.
[7] C. Dye,et al. Estimates of world-wide distribution of child deaths from acute respiratory infections. , 2002, The Lancet. Infectious diseases.
[8] S. Madhi,et al. Impact of human immunodeficiency virus type 1 on the disease spectrum of Streptococcus pneumoniae in South African children , 2000, The Pediatric Infectious Disease Journal.
[9] G. Siber,et al. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] G. Siber,et al. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] F. Shann. Etiology of severe pneumonia in children in developing countries , 1986, Pediatric infectious disease.